Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05481593 · ClinicalTrials.gov registry record · NA
An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
NCT05481593: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT05481593 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 212 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05481593, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
Study Summary
The purpose of this study to pilot test an accessible and inclusive artificial intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4CHRON) for health-related quality of life for adults with impaired mobility and chronic medical conditions.
Primary Outcome
Enabled version of Short-Form 36 (SF-36E)
Interventions
- BEHAVIORAL Scheduled Coaching + Gamified Rewards
- BEHAVIORAL Scheduled Coaching Calls + Independent Rewards
- BEHAVIORAL No Scheduled Coaching Calls + Gamified Rewards
- BEHAVIORAL No Scheduled Coaching Calls + Independent rewards
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
What the finished NCT05481593 record still lists
NCT05481593 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 4 interventions - of which Scheduled Coaching + Gamified Rewards is the first listed.
NCT05481593 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05481593 about?
NCT05481593 is a clinical study titled "An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform". The purpose of this study to pilot test an accessible and inclusive artificial intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4CHRON) for health-related quality of life for adults with impaired mobility and chronic medical conditions.
What is the current status of trial NCT05481593?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2024-02-01. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT05481593?
The interventions under investigation include: Scheduled Coaching + Gamified Rewards (BEHAVIORAL), Scheduled Coaching Calls + Independent Rewards (BEHAVIORAL), No Scheduled Coaching Calls + Gamified Rewards (BEHAVIORAL), No Scheduled Coaching Calls + Independent rewards (BEHAVIORAL).
Who is sponsoring clinical trial NCT05481593?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05481593's enrollment target sits among peer trials
212 489th of 2000 higher than 1,511 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI